Saline Laxatives Market Insights
Rising incidence of patients suffering from irritable bowel syndrome, Parkinson’s disease, multiple sclerosis, and pregnancy may lead to rising number of constipation cases, which is further expected to drive the market growth over the forecast period. For instance, according to the study published in National Center for Biotechnology Information (NCBI), in December 2018, around 2%-20% of multiple sclerosis patients, globally, suffered from constipation. Manufacturers are focused on offering innovative products such as Pedia-Lax watermelon flavored oral chewable tablets for pediatrics offered by C.B. Fleet Company, Incorporated. Moreover, enemas is introduced in the market by the manufacturers such as C.B. Fleet Company and others.
The global saline laxatives market is estimated to be valued at US$ 396.3 million in 2019, and is expected to exhibit a CAGR of 5.0% during the forecast period (2019–2027).
Figure 1. Global Saline Laxatives Market Share (%), By Age Group, (2019 & 2027)
Source: Coherent Market Insights Analysis (2019)
Adoption of inorganic growth strategies such as acquisition and partnerships by major players in the market is expected to drive global saline laxatives market growth
Rising adoption of acquisition and collaboration strategies by market players is expected to boost the saline laxatives market growth during the forecast period. For instance, in January 2017, Prestige Consumer Health Inc. acquired C.B. Fleet Company, a manufacturer of women’s care and other over-the-counter (OTC) healthcare products. The acquisition enhanced Prestige’s offering in the women health and gastrointestinal segment and strengthened its position in the global market.
Moreover, increasing product launches by market players is expected to drive growth of the market over the forecast period. For instance, in August 2017, Pendopharm, a provider of laxatives, launched four products such as Lax-A-Day, Lax-A Fibre, Lax-A Senna, and Lax-A Nema. The Lax-A Nema is a single dose rectal solution for adults that provides immediate relief from occasional constipation (130 ml).
Global Saline Laxatives Market- Restraints
Availability of alternative prescription (Rx) and over-the-counter (OTC) laxative options are expected to hinder growth of the saline laxatives market over the forecast period. For instance, there are several alternative laxative options (which are highly preferred) available for saline laxatives, which include bulk-forming laxatives, osmotic laxatives, stimulant laxatives, stool softener laxatives, lubricant laxatives, and prokinetic laxatives.
Global Saline Laxatives Market- Regional Analysis
Regional segmentation of the global saline laxatives market comprises North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.
Among regions, North America is expected to hold a dominant position in the global saline laxatives market, owing to rising prevalence of chronic constipation in the region that is expected to drive saline laxatives market growth during the forecast period. For instance, according to a report published by the Canadian Digestive Health Foundation, in 2014, 1 out of 4 people living in Canada suffered from symptoms of constipation. Chronic constipation rate in women are almost twice than men in Canada.
Moreover, Europe is expected to witness significant growth followed by Asia Pacific, in the global saline laxatives market over the forecast period, owing to increasing incidence of constipation that is expected to drive growth of the market in these regions. For instance, according to a report published by Coloplast, a global leading player in ostomy care, urology and continence care, and wound and skin care, 1 in 7 adults were affected by constipation during 2014 - 2015 in the U.K., wherein 1 in every 3 children were affected by constipation during 2014-2015.
Moreover, according to the study published in the World Journal of Gastroenterology, August 2016, in Hong Kong and South Korea around 12% and 28% pediatric patients suffered from functional constipation respectively.
Figure 2: Global Saline Laxatives Market Share (%), By Region, (2019 & 2027)
Source: Coherent Market Insights Analysis (2019)
Global Saline Laxatives Market- Competitive Landscape
Key players operating in the global saline laxatives market include Bayer AG, Beutlich Pharmaceuticals LLC., Prestige Consumer Healthcare Inc, Cardinal Health, Inc., Major Pharmaceuticals, Dynarex Corporation, Pharmascience Inc, and Salix Pharmaceuticals.
Saline laxatives are soluble inorganic salts that contain multivalent cations or anions. Examples of saline laxatives include citrate salts (Royvac), magnesium preparations (Phillips’ Milk of Magnesia), sulfate salts, and sodium phosphate. Saline laxatives can be administered orally as well rectal route of administration. Oral saline (salt) laxatives are used for rapid emptying lower intestine and bowel. Oral saline laxatives are most commonly used in treating occasional constipation. Rectal saline laxatives have applications in various health conditions such as during labor pain, post birth, during preparation for examination or surgery, to normalize bowel functions, and in post-surgical conditions.
Increasing prevalence of constipation due to sedentary lifestyle and low consumption of fluids and fiber diet are major factors that are expected to drive the global saline laxative market growth over the forecast period. For instance, according to a National Center for Biotechnology Information (NCBI) study 2016, chronic constipation is a common complaint received by both gastroenterologists and primary care physicians, with prevalence estimates ranging from 1% to 8% among the North America population. Moreover, constipation occurs more frequently in women, with a female/male ratio ranging from 1.01 to 3.77.
Various saline (salt) solutions such as magnesium citrate, magnesium hydroxide (MOM), magnesium sulfate (Epsom salts), sodium phosphates, and polyethylene glycol are used in preparing oral saline laxatives. Moreover, manufacturers are focused on offering saline laxatives for oral use, which is expected to drive growth of the oral segment in saline laxatives market over the forecast period. For instance, Pendopharm offers LAX-A DAY, polyethylene Glycol 3350 Powder (salt) for oral solution. The product was launched in August 2017.
Key features of the study:
“*” marked represents similar segmentation in other categories in the respective section.